Polysorbate 80 (HX2)™ Is in Compliance With The Chinese Pharmacopoeia

We are pleased to inform you that we have submitted a Drug Master File to the CDE (Center for Drug Evaluation, National Medical Products Administration) for our Polysorbate 80 (HX2)™.

Polysorbate 80 (HX2)™, our ultrapure polysorbate 80, is now in compliance with the United States Pharmacopeia (USP), the European Pharmacopoeia (EP), the Japanese Pharmacopoeia (JP), and the Chinese Pharmacopoeia (ChP for injection).

Polysorbate 80 (HX2)™ can be used for the development of a wide range of pharmaceutical products intended for the Chinese market.